Omega Therapeutics | IPO Presentation Deck | 33 slides · page 21 of 33
The slide compares tumor luminescence (growth) and body weight change (toxicity) across three groups: negative control, OEC candidate, and Sorafenib.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 source-note 1/1 title 2/2
Components 5
line line source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.